FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Bristol-Myers Squibb news from FiercePharma

News

BMS: Buyer or buyout target?

Market-watchers love to speculate. Their latest topic? Bristol-Myers Squibb, which has been paring away its "non-core" businesses over the last few months. Most recently, Bristol agreed to Read more...

Bristol profits leap on Plavix sales

Bristol-Myers Squibb's third-quarter results show what one big drug can do. Net income more than doubled to $858 million on revenues of $5.1 billion--and Plavix was the biggest reason. Third quarter Read more...

BMS cancer med could earn $500M

Analysts are rubbing their hands over the FDA's approval of Ixempra, a Bristol-Myers Squibb breast cancer treatment, predicting $500 million in annual sales by 2010. The drug got the agency's nod as Read more...
Tags: FDA   Roche   BMS   Ixempra   Bristol-Myers Squibb   Xeloda  

Press Releases

Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Dise

Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease First-in-Class Compound Designed to Improve Clinical Outcomes Read more...

PRESS RELEASE: Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million

Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million NEW YORK, Dec. 17 -- Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Read more...

PRESS RELEASE: Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation

Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community Expects Productivity Transformation Initiative to Generate Pre-Tax Read more...

PRESS RELEASE: Bristol-Myers Squibb to Webcast December 5 Business Update

Bristol-Myers Squibb to Webcast December 5 Business Update NEW YORK, Nov. 28 -- Bristol-Myers Squibb Company will provide a business update to the investment community on Wednesday, December 5 from Read more...

PRESS RELEASE: Bristol-Myers Squibb Ends Cancer Drug Deal with Pierre Fabre

Bristol-Myers Squibb Ends Cancer Drug Deal with Pierre Fabre PRINCETON, N.J., and PARIS, Nov. 23 -- Bristol- Myers Squibb Company and Pierre Fabre Medicament reported today that they are terminating Read more...

Get more Bristol-Myers Squibb coverage at: